Tumor suppressive activity of AHR in environmental arsenic-induced carcinogenesis

Toxicol Appl Pharmacol. 2023 Nov 5:116747. doi: 10.1016/j.taap.2023.116747. Online ahead of print.ABSTRACTThe aryl hydrocarbon receptor (AHR) is a highly conserved pleiotropic transcription factor that senses environmental pollutants, microbial products, and endogenous ligands. The transcriptional targets of AHR include phase I and phase II detoxification enzymes, as well as numerous signaling molecules that affect a wide spectrum of biological and biochemical processes in a manner of cellular context-dependent. In this review, we systematically assess the latest discoveries of AHR in carcinogenesis with an emphasis on its tumor suppressor-like property that represses the expression of genes in oncogenic signaling pathways. Additionally, we outline recent progress in our studies on the interaction among AHR, TGFb and NRF2 in cellular responses to arsenic and malignant transformation. Our findings indicate that AHR antagonized TGFb and NRF2, suggesting that AHR could serve as a potential tumor suppressor in arsenic-induced carcinogenesis. Notably, while AHR can exhibit both oncogenic and tumor-suppressive properties in cancer development and the generation of the cancer stem-like cells (CSCs), the tumor suppressor-like effect of AHR warrants further extensive exploration for the prevention and clinical treatment of cancers.PMID:37935250 | DOI:10.1016/j.taap.2023.116747

Source: Toxicology and Applied Pharmacology - November 7, 2023 Category: Toxicology Authors: Ziwei Wang Yao Fu Akimasa Seno Zhuoyue Bi Aashna S Pawar Haoyan Ji Bandar Saeed Almutairy Yiran Qiu Wenxuan Zhang Chitra Thakur Fei Chen Source Type: research